HUTCHMED (China) (HMDCF) EPS (Diluted) (2015 - 2021)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) EPS (Diluted) (2015 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | -0.40 |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -1.49 |
| Sep 28, 2021 | 1.22 |
| Jun 30, 2021 | 0.44 |
| Mar 31, 2021 | 0.30 |
| Jun 30, 2020 | 0.17 |
| Mar 31, 2020 | 0.20 |
| Dec 31, 2019 | -0.28 |
| Sep 30, 2019 | -0.26 |
| Jun 30, 2019 | -0.75 |
| Mar 31, 2019 | 0.25 |
| Dec 31, 2018 | 0.17 |
| Sep 30, 2018 | 0.10 |
| Jun 30, 2018 | 0.57 |
| Mar 31, 2018 | -0.18 |
| Jun 30, 2016 | 0.27 |
| Jun 30, 2015 | 0.22 |